Home Stock

Stock Research: Gilead

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Gilead

NSQ:GILD US3755581036
68
  • Value
    82
  • Growth
    56
  • Safety
    Safety
    64
  • Combined
    95
  • Sentiment
    19
  • 360° View
    360° View
    68
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Gilead Sciences, Inc. is a biopharmaceutical company focused on medicines for life-threatening diseases. It operates in the biopharmaceutical industry, with marketed products including Biktarvy and others. The company operates in more than 35 countries worldwide. In the last fiscal year, the company had a market cap of $135,066 million, profits of $22,503 million, revenue of $28,754 million, and 17,600 employees.

more

ANALYSIS: With an Obermatt 360° View of 68 (better than 68% compared with alternatives), overall professional sentiment and financial characteristics for the stock Gilead are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Gilead. The consolidated Value Rank has an attractive rank of 82, which means that the share price of Gilead is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 82% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 56, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 64. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 19. Professional investors are more confident in 81% other stocks. ...read more

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Dividend Yield
Country USA
Industry Biotechnology
Size XX-Large
Website gilead.com
Index
NASDAQ 100
NASDAQ
D.J. US Health Care
S&P 500
Gilead stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
82 67 n/a n/a
Growth
56 63 n/a n/a
Safety
Safety
64 70 n/a n/a
Sentiment
19 98 n/a n/a
360° View
360° View
68 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
18 43 n/a n/a
Opinions Change
27 86 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
19 79 n/a n/a
Sentiment
19 98 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
82 67 n/a n/a
Growth
56 63 n/a n/a
Safety Safety
64 70 n/a n/a
Combined
95 86 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
73 28 n/a n/a
Price vs. Earnings (P/E)
10 57 n/a n/a
Price vs. Book (P/B)
13 16 n/a n/a
Dividend Yield
100 98 n/a n/a
Value
82 67 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
27 26 n/a n/a
Profit Growth
100 84 n/a n/a
Capital Growth
35 33 n/a n/a
Stock Returns
52 83 n/a n/a
Growth
56 63 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
10 64 n/a n/a
Refinancing
75 24 n/a n/a
Liquidity
85 89 n/a n/a
Safety Safety
64 70 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Gilead and broaden your portfolio horizons.

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Nexstar

NSQ:NXST
Country: USA
Industry: Broadcasting
Size: X-Large
Full Stock Analysis

Toll Brothers

NYQ:TOL
Country: USA
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews